Checkpoint Therapeutics Reports First Quarter 2018 Financial Results and Recent Corporate Highlights May 10, 2018
Fortress Biotech Reports First Quarter 2018 Financial Results and Recent Corporate Highlights May 10, 2018
Avenue Therapeutics Reports First Quarter 2018 Financial Results and Recent Corporate Highlights May 03, 2018
Caelum Biosciences Submits Draft Registration Statement on Form S-1 to the Securities and Exchange Commission Apr 20, 2018
Checkpoint Therapeutics Reports Preclinical Data on BET Inhibitor CK-103 at the American Association for Cancer Research Annual Meeting Apr 18, 2018
Mustang Bio Reports Fourth Quarter and Full-Year 2017 Financial Results and Recent Corporate Highlights Mar 29, 2018
Avenue Therapeutics Receives Notices of Allowance for Patent Applications Covering Methods of Administration for Intravenous Tramadol Mar 28, 2018
Caelum Biosciences Announces Updated Phase 1b Data Presented at 16th International Symposium on Amyloidosis Mar 27, 2018
